Patients with hormone-positive breast cancer are usually treated with anti-hormone therapies such as tamoxifen or aromatase inhibitors. However, many of these patients are resistant to these drugs or develop resistance during treatment, allowing their breast cancer to return. By collecting molecular data from patient tumour samples he hopes to aid the development of new tests to predict response so that patients receive the best possible treatment. Professor Dixon is a breast cancer surgeon at the Western General Hospital in Edinburgh and many of his patients consent to donate samples of their tumours for research.
Breast screening has increased the number of mastectomies
HRT increases the chance of breast cancer - The Scotsman
Who is Mike Dixon? I am a surgeon working in the largest, busiest Breast Unit in the United Kingdom. Over patients every year with breast cancer are managed within the Unit at the Western General Hospital. The Unit is also the regional centre for management of all screen detected breast cancers in the south east of Scotland.
Breast Surgery meets the needs of surgeons in higher training and practising consultants for a contemporary and evidence-based account of this sub-specialty that is relevant to their general surgical practice. It is a practical reference source incorporating the most current information on recent developments, management issues and operative procedures. The text is thoroughly referenced and supported by evidence-based recommendations wherever possible, distinguishing between strong evidence to support a conclusion, and evidence suggesting that a recommendation can be reached on the balance of probabilities. For this Sixth Edition the authorship team across the series has been expanded to include additional European and World experts, with an increased emphasis on global practice. Throughout all six volumes the contents have been extensively revised in line with recently published evidence.
Former footballers five times more likely to die from Alzheimer's disease according to landmark Scottish study. The year-old had been contacted to go for screening just after her 50th birthday but there had been no symptoms so she did not feel worried. Pamela was unable to continue with her work as an administrator for the Scottish Prisons Service for ten months while she underwent the lengthy process of radiotherapy treatment. Doctors have since found out that the cancer has spread to her bones but her prognosis is good at the moment. The Health Hero award aims to recognise the unsung heroes of the health service, whether it is a brilliant consultant, a nurse who always made you smile or a care assistant who went beyond the call of duty.